References
- IzziVLakkalaJDevarajanRExpression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemiaLeuk Res Rep2017991329270355
- GanapuleANemaniSKorulaAAllogeneic stem cell transplant for acute myeloid leukemia: evolution of an effective strategy in IndiaJ Glob Oncol20173677378129244983
- FontanaMCMarconiGFeenstraJDMChromothripsis in acute myeloid leukemia: biological features and impact on survivalLeukemia Epub20171218
- ChenJDoroudiMCheungJGrozierALSchwartzZBoyanBDPlasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3)Cell Signal201325122362237323896121
- TakataHKudoMYamamotoTIncreased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinomaOncol Lett20161264896490428101228
- ChayDChoHLimBJER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139Int J Oncol201037239941220596667
- RamosFSSerinoLTCarvalhoCMPDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancerGenet Mol Res20151426960696726125904
- SunYHuskeyRLTangLAdverse effects of intravenous vancomycin-based prophylaxis during therapy for pediatric acute myeloid leukemiaAntimicrob Agents Chemother2018623e01838e0191729229640
- SexauerANTasianSKTargeting FLT3 signaling in childhood acute myeloid leukemiaFront Pediatr2017524829209600
- SteinEMWalterRBErbaHPA phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemiaBlood2018131438739629196412
- ZhouJDMaJCZhangTJHigh bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemiaOncotarget2017854919799198929190891
- GuoQLuanJLiNMicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysisOncotarget2017851891308914129179505
- ChungHChoHPerryCSongJYlayaKLeeHKimJHDown-regulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancerBiomarkers201318757357923957851
- JiaZZhaoWFanLShengWThe expression of PCNA, c-erbB-2, p53, ER and PR as well as atypical hyperplasia in tissues nearby the breast cancerJ Mol Histol201243111512022057681
- KimBSrivastavaSKKimSHCaspase-9 as a therapeutic target for treating cancerExpert Opin Ther Targets201519111312725256701
- SandhuCConnorMKislingerTSlingerlandJEmiliAGlobal protein shotgun expression profiling of proliferating mcf-7 breast cancer cellsJ Proteome Res20054367468915952714
- Whang-PengJHendersonESKnutsenTFreireichEJGartJJCyto-genetic studies in acute myelocytic leukemia with special emphasis on the occurrence of Ph1 chromosomeBlood19703644484575271809
- ZapfBCarpenterRJ3rdSnyderGGUlcerating tumor of tonsil and neck mass as occurrence of acute myelocytic leukemiaOtolaryngol Head Neck Surg19818945605636793965
- Corazao-RozasPGuerreschiPAndréFMitochondrial oxidative phosphorylation controls cancer cell’s life and death decisions upon exposure to MAPK inhibitorsOncotarget2016726394733948527250023
- MooltenFLTumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategyCancer Res19864610527652813019523
- ErikssonMPeña-MartínezPRamakrishnanRAgonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cellsBlood Adv20171232046205729296851
- MakPYMakDHMuHApoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLApoptosis201419469870724337870
- ChoiCHXuHBarkHLeeTBYunJKangSIOhYKBalance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell linesLeuk Res20073191267127617218010
- LiQHuaiLZhangCIcaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathwaysInt J Hematol201397561762323550021